IMPLEMENTATION SCIENCE
Maximising the impact of HIV prevention and treatment by bridging the gap between research and clinical practice.
ViiV Healthcare, the only company solely focused on preventing, treating, and ultimately curing HIV, is dedicated to advancing HIV Implementation Science. We invest in research to bridge the gap between clinical trials and real-world HIV care, aiming to improve testing, diagnosis, retention in care, and viral load suppression.
Implementation Science is focused on putting research into practice, in real-world settings. We collaborate with researchers, public health leaders, academia, governments, and community organisations to maximise the impact of implementation research. Our goal is to enhance the lives of those affected by HIV and reduce transmission of the virus.
We are dedicated to identifying strategies to bridge the gap between the availability of effective HIV medications and the access and use of those medicines to better the lives of people living with HIV and of people who can benefit from PrEP (Pre-Exposure Prophylaxis).
Digital Innovation and Implementation Science
Digital innovation and implementation science leverage research and digital solutions to transform HIV treatment and prevention. Striving to lead the industry, our solutions include developing support tools, educational materials, diagnostic innovations, all with the goal of improving experiences for people impacted by HIV and healthcare providers.
NP-GBL-HVU-WCNT-250001 | March 2026
If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the GSK Reporting Tool link https://gsk.public.reportum.com/. By reporting side effects, you can help provide more information on the safety of this medicine.
If you are from outside the UK, you can report adverse events to GSK/ ViiV by selecting your region and market, here.
